Chugai Pharmaceutical earnings (net income)
Chugai Pharmaceutical (4519) earned a net income of $2.72 B in fiscal year 2025, +12.1% compared with the year before. Net profit margin: 34.5% of revenue.
Earnings 2025$2.72 B
Change+12.1%
World rank#277
Market cap$74.85 B
Net income by year
By year
| Year | Value | Change |
|---|---|---|
| 2025 | $2.72 B | +12.1% |
| 2024 | $2.42 B | +19.0% |
| 2023 | $2.04 B | −13.1% |
| 2022 | $2.34 B | — |
Converted to US dollars at today’s exchange rate. Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.